An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma

An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma

BackgroundFor pancreatic ductal adenocarcinoma (PDAC) patients, chemotherapy failure is the major reason for postoperative recurrence and poor outcomes. Establishment of novel biomarkers and models for predicting chemotherapeutic efficacy may provide survival benefits by tailoring treatments.Methods...

Full description

Bibliographic Details
Main Authors: Zengyu Feng, Kexian Li, Jianyao Lou, Yulian Wu, Chenghong Peng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
PDAC
EMT
adjuvant chemotherapy
sensitivity
disease-free survival
risk score
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.665161/full

Similar Items

Similar Items